ArticleActa pharmaceutica Sinica. B2023

Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer.

Yixin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.